We are live on ! Find out more
HUMAW

Humacyte Inc Warrant
HUMAW

Delisted

HUMAW was delisted on the 25th of August, 2026.

12 hedge funds and large institutions have $1.02M invested in Humacyte Inc Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1212 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

35% less capital invested

Capital invested by funds: $1.58M → $1.02M (-$560K)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
3
Closed
2
Calls
$263K
Puts
Net Calls
+$263K
Net Calls Change
-$320K

HUMAW Hedge Fund Activity: Q2 2022 in Review

12 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2022, worth a combined $1.02M — down 35% from $1.58M a quarter earlier.

Fund positioning in HUMAW was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was Josh Arnold Investment Consultant, opening a new position worth an estimated $299K. The largest seller was Alpine Global Management, exiting entirely with an estimated $91K sold.

  • 12 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $1.02M of Humacyte Inc Warrant stock for Q2 2022, down 35% quarter-over-quarter.
  • 2 funds opened new Humacyte Inc Warrant positions in Q2 2022 and 2 closed out, a net change of 0 holders.
  • The largest Humacyte Inc Warrant buyer in Q2 2022 was Josh Arnold Investment Consultant, an estimated $299K added.
  • The largest Humacyte Inc Warrant seller in Q2 2022 was Alpine Global Management, an estimated $91K sold.

Based on aggregated 13F filings for Q2 2022.